You are here:
Home
>
Industries
>
Life Sciences
>
Pharmaceutical
Life Sciences >> Pharmaceutical
Wuxi Apptec Co Bigger profits expected
01/22/2009
SFDA warned adverse reaction of cefradine
01/20/2009
Hefei to found biggest Hepatitis B Vaccine base
01/16/2009
China Biologic receives short-term loan from Bank of China
01/15/2009
Traditional Chinese medicine under attack from illegal ads
01/14/2009
Daiichi Sankya seeks Chinese nod for silodosin
01/12/2009
SFDA requires stopping the production, selling, and use of fenfluramine hydrochloride raw materials and preparations
01/12/2009
SFDA issues Requirements on Special Approval of New Drug Registration
01/12/2009
China campus
01/10/2009
Glaxo seeks 'bolt-on' links for new drugs
01/10/2009
Stricter supervision on cephalosporin injections using butyl rubber closures
01/07/2009
Professor Lin Ruichao elected foreign member of French National Academy of Pharmacy
01/05/2009
SFDA further strengthens supervision on cephalosporin injections using butyl rubber closures
01/05/2009
Gold sparkles in the economic darkness
01/01/2009
Potent MS medicine a lifeline for drug firm
12/29/2008
US$1.4b team-up to create new drugs
12/24/2008
Jewelry retailer goes slow in China
12/20/2008
Outlook on Chinese demand for gold in 2009 to be strong
12/20/2008
Dubai's jewelers rue the 20 percent price increase
12/19/2008
Gold's new luster in troubled times
12/18/2008
336Items 20 items per page Pages:17 Current page: 2
[ 1 ]
[ 2 ]
[ 3 ]
[ 4 ]
[ 5 ]
More
Home
Industries
Consumer Goods
Textile
Households
Agriculture
Food&Beverage
Manufacturing
Energy
Metals&Minerals
Material
Machinery
Chemical
Automotive
Life Sciences
Biotechnology
Pharmaceutical
Medical
Technology&Media
Hardware
Software
Telecommunications
Cyber Economy
Media
Consumer Electronics
Public Sector
Training
Infrastructure
Environment
Finance Service
Retailing
Real Estate
Logistics
Tourism
Economy
Macro Economy
Trade
Investment
Laws&Regulations
Other
Stocks
News&Review
Announcement
Balance Sheet
Income Statement
Cash Flow Statement
Our Services
Investment
Research
Consulting
Due Dilegence
Projects
Charts
Mailing List
About Us
About InvestToChina
Corporate News
Our Team
Contact Us
2008-2009 www.investtochina.com All Rights Reserved